Fig. 3
From: Human clinical trial of plasmapheresis effects on biomarkers of aging (efficacy and safety trial)

Significant lipid profile alterations following 8 plasmapheresis sessions. Legend: Box plot comparing levels of total cholesterol, non-HDL cholesterol, triglycerides (TAG), apolipoprotein A, and apolipoprotein B1 before and after 8 plasmapheresis sessions. The plot displays the median, quartiles, and range, with significant changes marked as * (p < 0.05), ** (p < 0.01), and *** (p < 0.001). ApoA-I is the main protein component of HDL cholesterol (the “good” cholesterol).